PHILLIPS BARCLAY A 4
4 · G1 Therapeutics, Inc. · Filed Dec 6, 2017
Insider Transaction Report
Form 4
PHILLIPS BARCLAY A
SVP & Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2017-12-06+250,000→ 250,000 totalExercise: $19.46Exp: 2027-11-13→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option will vest as to 25% of the shares on the first anniversary of the commencement of the Reporting Person's employment (which began on November 13, 2017) and as to an additional 1/48th of the shares monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.